Vitix® - A new treatment for vitiligo? [1]

International Journal of Dermatology

Volumn 44, Issue 11, 2005, Pages 969-970

  Schallreuter, Karin U ^a   Rokos, Hartmut ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CATALASE; CUCUMIS MELO EXTRACT; DERMATOLOGICAL AGENT; DRUG VEHICLE; HYDROGEN PEROXIDE; PALM OIL; PLANT MEDICINAL PRODUCT; PSEUDOCATALASE; REACTIVE OXYGEN METABOLITE; SUNSCREEN; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; VITIX;

CANTALOUPE; CREAM; DRUG FORMULATION; DRUG MECHANISM; FOURIER TRANSFORMATION; HUMAN; LETTER; SUN EXPOSURE; TREATMENT OUTCOME; ULTRAVIOLET B RADIATION; VITILIGO; DRUG COMBINATION; EPIDEMIOLOGY; FEMALE; FOLLOW UP; MALE; METHODOLOGY; NEWBORN; PUVA; RISK ASSESSMENT; SKIN DISEASE; TREATMENT FAILURE;

CATALASE; DERMATOLOGIC AGENTS; DRUG COMBINATIONS; FACIAL DERMATOSES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT, NEWBORN; MALE; PUVA THERAPY; RISK ASSESSMENT; SAMPLING STUDIES; SUPEROXIDE DISMUTASE; TREATMENT FAILURE; VITILIGO;

EID: 28444491131     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2005.02653.x     Document Type: Letter

References (10)

1. Maresca V, Roccella M, Roccella F, et al. Increased sensitivity to peroxidative agents as a possible pathogenic factor of melanocyte damage in vitiligo. J Invest Dermatol 1997; 109: 310-313.
2. Dell'Anna ML, Urbanelli S, Mastrofrancesco A, et al. Alterations of mitochondria in peripheral blood mononuclear cells of vitiligo patients. Pigment Cell Res 2003; 16: 553-559.
3. Dell'Anna ML, Maresca V, Briganti S, et al. Mitochondrial impairment in peripheral blood mononuclear cells during the active phase of vitiligo. J Invest Dermatol 2001; 117: 908-913.
4. 2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase. J Invest Dermatol Symp Proc 1999; 4: 91-96.
5. 4 -dependent processes? J Invest Dermatol 2001; 116: 167-174.
6. 2 stress. J Invest Dermatol 2004; 122: 307-313.
7. Schallreuter KU, Wood JM, Lemke KR, et al. Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short-term UVB exposure: a case study on 33 patients. Dermatology 1995; 190: 223-229.
8. Schallreuter KU, Moore J, Behrens-Williams S, et al. Rapid initiation of repigmentation in vitiligo with Dead Sea climatotherapy in combination with pseudocatalase (PC-KUS). Int J Dermatol 2002; 411: 482-487.
9. 2: more evidence for oxidative stress in vitiligo. Biochem Biophys Res Commun 2004; 315: 502-508.
10. Schallreuter KU, Moore J, Behrens-Williams S, et al. In vitro and in vivo identification of pseudocatalase activity in Dead Sea water using Fourier transform Raman spectroscopy. J Raman Spectrosc 2002; 33: 586-592.